| Literature DB >> 27320652 |
Tatiana Rocha Silva1, Luciana Macedo de Resende2, Marco Aurélio Rocha Santos3.
Abstract
INTRODUCTION: The vestibular evoked myogenic potential is a potential of mean latency that measures the muscle response to auditory stimulation. This potential can be generated from the contraction of the sternocleidomastoid muscle and also from the contraction of extraocular muscles in response to high-intensity sounds. This study presents a combined or simultaneous technique of cervical and ocular vestibular evoked myogenic potential in individuals with changes in the vestibular system, for use in otoneurologic diagnosis.Entities:
Keywords: Doenças vestibulares; Labyrinth vestibule; Motor evoked potential; Nervo vestibular; Potencial evocado motor; Saccule and utricle; Sáculo e utrículo; Vestibular disorders; Vestibular nerve; Vestíbulo do labirinto
Mesh:
Year: 2016 PMID: 27320652 PMCID: PMC9444740 DOI: 10.1016/j.bjorl.2016.04.017
Source DB: PubMed Journal: Braz J Otorhinolaryngol ISSN: 1808-8686
Measures of central tendency, dispersion, and position for latency (ms) and amplitude (μV) for combined cervical and ocular VEMP for individuals with vestibular hyporeflexia and individuals in the control group (CG1).
| Wave parameters | Hyporeflexia | CG1 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Mean | Median | SD | Max. | Min. | Mean | Median | SD | Max. | Min. | |
| | ||||||||||
| Ampl P13 | 26.16 | 22.72 | 19.03 | 74.47 | 0.00 | 34.48 | 32.63 | 18.16 | 74.22 | 7.64 |
| Ampl N23 | 29.80 | 28.41 | 18.29 | 67.76 | 0.00 | 57.20 | 43.32 | 39.27 | 169.58 | 10.58 |
| Inter ampl | 56.07 | 55.97 | 33.57 | 128.73 | 0.00 | 91.67 | 76.51 | 54.38 | 225.27 | 18.22 |
| Lat P13 | 15.94 | 14.60 | 5.70 | 31.30 | 0.00 | 12.82 | 12.90 | 1.07 | 14.90 | 10.70 |
| Lat N23 | 23.33 | 22.05 | 6.18 | 37.80 | 0.00 | 22.19 | 21.90 | 1.46 | 24.90 | 20.50 |
| | ||||||||||
| Ampl N10 | 2.80 | 1.52 | 3.80 | 15.81 | 0.09 | 2.66 | 2.04 | 1.32 | 5.87 | 1.02 |
| Ampl P15 | 2.64 | 1.67 | 3.31 | 12.95 | 0.10 | 3.34 | 2.60 | 1.98 | 8.82 | 1.22 |
| Inter ampl | 5.44 | 3.28 | 7.04 | 28.76 | 0.19 | 6.03 | 5.26 | 3.10 | 14.69 | 2.90 |
| Lat N10 | 12.37 | 11.20 | 3.17 | 20.20 | 8.30 | 10.26 | 10.25 | 0.79 | 12.00 | 8.70 |
| Lat P15 | 19.48 | 18.35 | 4.28 | 28.50 | 13.40 | 15.24 | 15.10 | 0.89 | 17.03 | 13.40 |
| | ||||||||||
| Ampl P13 | 19.34 | 15.33 | 13.59 | 51.41 | 0.00 | 26.53 | 22.89 | 13.37 | 66.69 | 9.08 |
| Ampl N23 | 18.66 | 13.58 | 13.34 | 47.07 | 0.00 | 44.07 | 37.26 | 21.66 | 96.86 | 17.31 |
| Inter ampl | 38.00 | 34.49 | 25.26 | 91.03 | 0.00 | 70.60 | 62.41 | 32.47 | 163.55 | 28.17 |
| Lat P13 | 17.50 | 16.45 | 5.92 | 28.30 | 0.00 | 12.99 | 12.75 | 1.05 | 15.10 | 10.90 |
| Lat N23 | 25.41 | 25.70 | 6.87 | 35.40 | 0.00 | 22.57 | 22.35 | 1.49 | 25.30 | 20.10 |
| | ||||||||||
| Ampl N10 | 1.91 | 0.86 | 2.67 | 12.19 | 0.00 | 2.25 | 2.18 | 0.92 | 4.02 | 1.04 |
| Ampl P15 | 1.92 | 0.68 | 2.56 | 10.60 | 0.00 | 2.55 | 2.68 | 0.83 | 4.09 | 1.12 |
| Inter ampl | 3.83 | 1.53 | 5.03 | 19.20 | 0.00 | 4.80 | 5.02 | 1.64 | 7.70 | 2.54 |
| Lat N10 | 12.94 | 12.80 | 5.51 | 28.30 | 0.00 | 10.52 | 10.50 | 0.89 | 11.90 | 8.80 |
| Lat P15 | 19.67 | 20.35 | 7.46 | 37.10 | 0.00 | 15.41 | 15.50 | 0.78 | 17.00 | 13.80 |
SD, standard deviation; Max., maximum, Min., minimum; St, stimulation; RE, right ear; LE, left ear; Ampl, amplitude; Lat, latency.
Measures of central tendency, dispersion, and position for latency (ms) and amplitude (μV) for combined cervical and ocular VEMP for individuals with Ménière's disease and individuals in the control group (CG2).
| Wave parameters | Ménière's disease | CG2 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Mean | Median | SD | Max. | Min. | Mean | Med. | SD | Max. | Min. | |
| | ||||||||||
| Ampl P13 | 25.96 | 24.54 | 13.18 | 52.02 | 4.31 | 43.68 | 45.02 | 19.06 | 77.98 | 7.64 |
| Ampl N23 | 34.59 | 31.42 | 20.25 | 85.63 | 6.90 | 62.28 | 60.49 | 27.16 | 111.38 | 10.58 |
| Inter ampl | 60.55 | 54.11 | 31.96 | 128.65 | 11.39 | 105.98 | 106.98 | 44.51 | 170.63 | 18.22 |
| Lat P13 | 15.08 | 13.90 | 3.12 | 23.50 | 11.60 | 13.40 | 13.45 | 0.96 | 14.90 | 11.60 |
| Lat N23 | 23.53 | 22.80 | 3.15 | 31.70 | 20.50 | 22.39 | 22.45 | 1.48 | 24.90 | 20.00 |
| | ||||||||||
| Ampl N10 | 4.40 | 1.87 | 7.63 | 28.81 | 0.14 | 2.33 | 2.05 | 0.80 | 5.25 | 1.04 |
| Ampl P15 | 5.95 | 1.89 | 12.32 | 45.18 | 0.15 | 3.21 | 3.05 | 1.18 | 8.48 | 1.13 |
| Inter ampl | 10.35 | 3.88 | 19.93 | 73.70 | 0.29 | 5.57 | 5.26 | 1.90 | 13.73 | 2.17 |
| Lat N10 | 12.18 | 10.95 | 3.49 | 22.60 | 9.10 | 10.40 | 10.40 | 0.84 | 12.10 | 9.20 |
| Lat P15 | 18.13 | 16.45 | 3.94 | 28.50 | 13.80 | 15.27 | 15.05 | 0.96 | 17.20 | 13.40 |
| | ||||||||||
| Ampl P13 | 23.73 | 21.98 | 13.77 | 54.56 | 0.00 | 37.64 | 32.47 | 15.63 | 76.04 | 14.97 |
| Ampl N23 | 29.42 | 29.60 | 16.19 | 68.61 | 0.00 | 51.47 | 51.34 | 16.88 | 95.88 | 23.74 |
| Inter ampl | 53.15 | 50.75 | 28.91 | 123.17 | 0.00 | 89.11 | 83.84 | 29.77 | 158.22 | 39.60 |
| Lat P13 | 14.05 | 13.40 | 4.82 | 22.70 | 0.00 | 13.18 | 13.30 | 1.16 | 14.90 | 11.20 |
| Lat N23 | 21.40 | 20.95 | 6.47 | 29.30 | 0.00 | 22.65 | 22.60 | 1.36 | 24.80 | 20.50 |
| | ||||||||||
| Ampl N10 | 1.58 | 1.55 | 0.88 | 3.37 | 0.00 | 2.64 | 2.50 | 0.96 | 5.34 | 1.07 |
| Ampl P15 | 1.72 | 1.79 | 1.11 | 4.76 | 0.00 | 3.29 | 3.02 | 1.31 | 8.29 | 1.12 |
| Inter ampl | 3.30 | 3.61 | 1.91 | 7.95 | 0.00 | 5.93 | 5.53 | 2.21 | 13.63 | 2.53 |
| Lat N10 | 11.95 | 11.05 | 4.42 | 28.30 | 0.00 | 10.49 | 10.30 | 0.94 | 12.20 | 9.10 |
| Lat P15 | 17.42 | 16.80 | 5.62 | 37.10 | 0.00 | 15.38 | 15.25 | 0.83 | 17.10 | 13.80 |
SD, standard deviation; Max., maximum, Min., minimum; St, stimulation; RE, right ear; LE, left ear; Ampl, amplitude; Lat, latency.
Comparison of individuals with vestibular hyporeflexia and the control group (CG1) for latency (ms) and amplitude (μV) for combined cervical and ocular VEMP.
| Parameters | Hyporeflexia | CG1 | |||||
|---|---|---|---|---|---|---|---|
| Mean | Median | SD | Mean | Median | SD | ||
| | |||||||
| Ampl P13 | 26.16 | 22.72 | 19.03 | 34.48 | 32.63 | 18.16 | 0.090 |
| Ampl N23 | 29.80 | 28.41 | 18.29 | 57.20 | 43.32 | 39.27 | |
| Inter ampl | 56.07 | 55.97 | 33.57 | 91.67 | 76.51 | 54.38 | |
| Lat P13 | 15.94 | 14.60 | 5.70 | 12.82 | 12.90 | 1.07 | |
| Lat N23 | 23.33 | 22.05 | 6.18 | 22.19 | 21.90 | 1.46 | 0.151 |
| | |||||||
| Ampl N10 | 2.80 | 1.52 | 3.80 | 2.66 | 2.04 | 1.32 | 0.088 |
| Ampl P15 | 2.64 | 1.67 | 3.31 | 3.34 | 2.60 | 1.98 | |
| Inter ampl | 5.44 | 3.28 | 7.04 | 6.03 | 5.26 | 3.10 | |
| Lat N10 | 12.37 | 11.20 | 3.17 | 10.26 | 10.25 | 0.79 | |
| Lat P15 | 19.48 | 18.35 | 4.28 | 15.24 | 15.10 | 0.89 | |
| | |||||||
| Ampl P13 | 19.34 | 15.33 | 13.59 | 26.53 | 22.89 | 13.37 | |
| Ampl N23 | 18.66 | 13.58 | 13.34 | 44.07 | 37.26 | 21.66 | |
| Inter ampl | 38.00 | 34.49 | 25.26 | 70.60 | 62.41 | 32.47 | |
| Lat P13 | 17.50 | 16.45 | 5.92 | 12.99 | 12.75 | 1.05 | |
| Lat N23 | 25.41 | 25.70 | 6.87 | 22.57 | 22.35 | 1.49 | |
| | |||||||
| Ampl N10 | 1.91 | 0.86 | 2.67 | 2.25 | 2.18 | 0.92 | |
| Ampl P15 | 1.92 | 0.68 | 2.56 | 2.55 | 2.68 | 0.83 | 0.054 |
| Inter ampl | 3.83 | 1.53 | 5.03 | 4.80 | 5.02 | 1.64 | |
| Lat N10 | 12.94 | 12.80 | 5.51 | 10.52 | 10.50 | 0.89 | |
| Lat P15 | 19.67 | 20.35 | 7.46 | 15.41 | 15.50 | 0.78 | |
SD, standard deviation; RE, right ear; LE, left ear; Ampl, amplitude; Lat, latency.
Bold values signify (p ≤ 0.05).
Wilcoxon's test (p ≤ 0.05).
t-test (p ≤ 0.05).
Values with trend toward statistical significance (p ≤ 0.10)
Comparison of individuals with Ménière's disease and the control group for latency (ms) and amplitude (μV) for combined cervical and ocular VEMP.
| Parameters | Ménière's disease | CG2 | |||||
|---|---|---|---|---|---|---|---|
| Mean | Median | SD | Mean | Median | SD | ||
| | |||||||
| Ampl P13 | 25.96 | 24.54 | 13.18 | 43.68 | 45.02 | 19.06 | |
| Ampl N23 | 34.59 | 31.42 | 20.25 | 62.28 | 60.49 | 27.16 | |
| Inter ampl | 60.55 | 54.11 | 31.96 | 105.98 | 106.98 | 44.51 | |
| Lat P13 | 15.08 | 13.90 | 3.12 | 13.40 | 13.45 | 0.96 | |
| Lat N23 | 23.53 | 22.80 | 3.15 | 22.39 | 22.45 | 1.48 | 0.083 |
| | |||||||
| Ampl N10 | 4.40 | 1.87 | 7.63 | 2.55 | 1.94 | 1.29 | 0.713 |
| Ampl P15 | 5.95 | 1.89 | 12.32 | 3.81 | 3.45 | 2.04 | |
| Inter ampl | 10.35 | 3.88 | 19.93 | 6.36 | 5.39 | 3.23 | 0.063 |
| Lat N10 | 12.18 | 10.95 | 3.49 | 10.05 | 10.10 | 0.56 | |
| Lat P15 | 18.13 | 16.45 | 3.94 | 14.61 | 14.60 | 0.59 | |
| | |||||||
| Ampl P13 | 23.73 | 21.98 | 13.77 | 37.64 | 32.47 | 15.63 | |
| Ampl N23 | 29.42 | 29.60 | 16.19 | 51.47 | 51.34 | 16.88 | |
| Inter ampl | 53.15 | 50.75 | 28.91 | 89.11 | 83.84 | 29.77 | |
| Lat P13 | 14.05 | 13.40 | 4.82 | 13.18 | 13.30 | 1.16 | |
| Lat N23 | 21.40 | 20.95 | 6.47 | 22.65 | 22.60 | 1.36 | 0.316 |
| | |||||||
| Ampl N10 | 1.58 | 1.55 | 0.88 | 2.64 | 2.50 | 0.96 | |
| Ampl P15 | 1.72 | 1.79 | 1.11 | 3.29 | 3.02 | 1.31 | |
| Inter ampl | 3.30 | 3.61 | 1.91 | 5.93 | 5.53 | 2.21 | |
| Lat N10 | 11.95 | 11.05 | 4.42 | 10.49 | 10.30 | 0.94 | |
| Lat P15 | 17.42 | 16.80 | 5.62 | 15.38 | 15.25 | 0.83 | |
SD, standard deviation; RE, right ear; LE, left ear; Ampl, amplitude; Lat, latency.
Bold values signify (p ≤ 0.05).
Wilcoxon's test (p ≤ 0.05).
t-test (p ≤ 0.05).
Values with trend toward statistical significance (p ≤ 0.10).
Figure 1Frequency distribution of the outcome of combined cervical and ocular VEMP, per the affected side, for individuals with vestibular hyporeflexia and for individuals with Ménière's disease (n = 30).
Figure 2Frequency distribution of the results of cervical VEMP, per ear, for individuals with vestibular hyporeflexia and for individuals with Ménière's disease (n = 60).
Figure 3Frequency distribution of the results of ocular VEMP, per ear, for individuals with vestibular hyporeflexia and for individuals with Ménière's disease (n = 60).
Figure 4Comparative analysis of the results of combined cervical and ocular VEMP and hearing, per ear, for individuals with vestibular hyporeflexia (n = 60). Chi-squared test (p ≤ 0.05) or Fisher's exact test (p ≤ 0.05).
Figure 5Comparative analysis of the results of combined cervical and ocular VEMP and hearing, per ear, for individuals with Ménière's disease (n = 60). Chi-squared test (p ≤ 0.05) or Fisher's exact test (p ≤ 0.05). #Values with trend toward statistical significance (p ≤ 0.10).
Comparison of the degree of hearing loss, per ear, in vestibular hyporeflexia and Ménière's disease in relation to the outcome of combined cervical and ocular VEMP (n = 60).
| VEMP results | |||||
|---|---|---|---|---|---|
| Normal | Altered | Odds ratio | 95% CI | ||
| | |||||
| Absent | 12 (20.00) | 26 (43.30) | – | – | – |
| Mild | 0 (0.00) | 12 (20.00) | 0.684 | 0.55–0.85 | |
| Moderate | 0 (0.00) | 6 (10.00) | 0.167 | – | – |
| Moderately severe | 1 (1.70) | 1 (1.70) | 1.000 | – | – |
| Severe | 0 (0.00) | 2 (3.30) | 1.000 | – | – |
| | |||||
| Absent | 14 (23.30) | 9 (15.00) | – | – | – |
| Mild | 7 (11.70) | 11 (18.30) | 0.162 | – | – |
| Moderate | 4 (6.70) | 11 (18.30) | 0,052 | 4.278 | 1.04–17.66 |
| Severe | 1 (1.70) | 2 (3.30) | 0.556 | – | – |
| Deep | 1 (1.70) | 0 (0.00) | 1.000 | – | – |
CI, confidence interval.
Bold values signify (p ≤ 0.05).
Chi-squared test (p ≤ 0.05) or Fisher's exact test (p ≤ 0.05).
Values with a tendency to statistical significance (p ≤ 0.10).